Literature DB >> 19967433

Sample size/power calculations for repeated ordinal measurements in population pharmacodynamic experiments.

Kayode Ogungbenro1, Leon Aarons.   

Abstract

Population pharmacodynamic experiments sometime involve repeated measurements of ordinal random variables at specific time points. Such longitudinal data presents a challenge during modelling due to correlation between measurements within an individual and often mixed-effects modelling approach may be used for the analysis. It is important that these studies are adequately powered by including an adequate number of subjects in order to detect a significant treatment effect. This paper describes a method for calculating sample size for repeated ordinal measurements in population pharmacodynamic experiments based on analysis by a mixed-effects modelling approach. The Wald test is used for testing the significance of treatment effects. This method is fast, simple and efficient. It can also be extended to account for differential allocation of subjects to the groups and unbalanced sampling designs between and within groups. The results obtained from two simulation studies using nonlinear mixed-effects modelling software (NONMEM) showed good agreement between the power obtained from simulation and nominal power used for sample size calculations.

Mesh:

Substances:

Year:  2009        PMID: 19967433     DOI: 10.1007/s10928-009-9144-6

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  19 in total

1.  Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED.

Authors:  Siv Jönsson; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

2.  Sample size for a two-group comparison of repeated binary measurements using GEE.

Authors:  Sin-Ho Jung; Chul W Ahn
Journal:  Stat Med       Date:  2005-09-15       Impact factor: 2.373

3.  Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons; Gordon Graham
Journal:  J Biopharm Stat       Date:  2006       Impact factor: 1.051

4.  Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

5.  Power and sample size calculations for exact conditional tests with ordered categorical data.

Authors:  J F Hilton; C R Mehta
Journal:  Biometrics       Date:  1993-06       Impact factor: 2.571

6.  Sample size calculations for ordered categorical data.

Authors:  J Whitehead
Journal:  Stat Med       Date:  1993-12-30       Impact factor: 2.373

7.  Population pharmacokinetic/pharmacodynamic modelling of the analgesic effects of tramadol in pediatrics.

Authors:  María J Garrido; Walid Habre; Ferdinand Rombout; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

8.  Population pharmacodynamic model for ketorolac analgesia.

Authors:  J W Mandema; D R Stanski
Journal:  Clin Pharmacol Ther       Date:  1996-12       Impact factor: 6.875

9.  Analysis of repeated categorical data using generalized estimating equations.

Authors:  S R Lipsitz; K Kim; L Zhao
Journal:  Stat Med       Date:  1994-06-15       Impact factor: 2.373

10.  A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.

Authors:  L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1994-09       Impact factor: 6.875

View more
  4 in total

1.  Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models.

Authors:  Camille Vong; Martin Bergstrand; Joakim Nyberg; Mats O Karlsson
Journal:  AAPS J       Date:  2012-02-17       Impact factor: 4.009

2.  Optimizing disease progression study designs for drug effect discrimination.

Authors:  Sebastian Ueckert; Stefanie Hennig; Joakim Nyberg; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-08-27       Impact factor: 2.745

3.  Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-06-10       Impact factor: 2.745

4.  Statistical power calculations for mixed pharmacokinetic study designs using a population approach.

Authors:  Frank Kloprogge; Julie A Simpson; Nicholas P J Day; Nicholas J White; Joel Tarning
Journal:  AAPS J       Date:  2014-07-11       Impact factor: 4.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.